Endoscopic therapies of gastroesophageal reflux disease.
The high prevalence of gastroesophageal reflux disease (GERD) in Western societies has accelerated the need for new modalities of treatment. Currently, medical and surgical therapies are widely accepted among patients and physicians. New potent antisecretory drugs and the development of minimally invasive surgery for the management of GERD are at present the pivotal and largely accepted approaches to treatment. The minimally invasive treatment revolution, however, has stimulated several new endoscopic techniques for GERD. Up to now, the data is limited and further studies are necessary to compare the advantages and disadvantages of the various endoscopic techniques to medical and laparoscopic management of GERD. New journal articles and abstracts are continuously being published. The Food and Drug Administration has approved 3 modalities, thus gastroenterologists and surgeons are beginning to apply these techniques. Further trials and device refinements will assist clinicians. This article will present an overview of the various techniques that are currently on study. This review will report the efficacy and durability of various endoscopic therapies for gastroesophageal reflux disease (GERD). The potential for widespread use of these techniques will also be discussed. Articles and abstracts published in English on this topic were retrieved from Pubmed. Due to limited number of studies and remarkable differences between various trials, strict criteria were not used for the pooled data presented, however, an effort was made to avoid bias by including only studies that used off-PPI scoring as baseline and intent to treat.
Iqbal
Atif
A
Department of Surgery, University of Missouri Columbia, One Hospital Drive, 65211, USA.
Salinas
Vanessa
V
Filipi
Charles-J
CJ
D017115:Catheter Ablation / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods; D004724:Endoscopy / Q000009:adverse effects / Q000379:methods*; D016145:Endoscopy, Digestive System / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods* / Q000592:standards; D005764:Gastroesophageal Reflux / Q000601:surgery / Q000628:therapy*; D015391:Gastroplasty / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods / Q000592:standards; D006801:Humans; D020100:Hydrogels / Q000627:therapeutic use; D006863:Hydrogen-Ion Concentration; D018579:Patient Selection; D019904:Polymethyl Methacrylate / Q000627:therapeutic use; D011145:Polyvinyls / Q000627:therapeutic use; D019736:Prostheses and Implants / Q000009:adverse effects / Q000592:standards; D013536:Suture Techniques / Q000009:adverse effects / Q000295:instrumentation; D013997:Time Factors
D020100:Hydrogels; D011145:Polyvinyls; C020320:ethylene-vinyl alcohol copolymer; D019904:Polymethyl Methacrylate